When was BoneSupport founded?
BoneSupport was founded in 1999.
Where is BoneSupport's headquarters?
BoneSupport's headquarters is located at Scheelevagen 19A, Lund.
What is BoneSupport's latest funding round?
BoneSupport's latest funding round is IPO.
How much did BoneSupport raise?
BoneSupport raised a total of $79.98M.
Who are the investors of BoneSupport?
Investors of BoneSupport include HealthCap Venture Capital, Industrifonden, Lundbeckfond Ventures, Tellacq, AP3 and 9 more.
Who are BoneSupport's competitors?
Competitors of BoneSupport include RxSight, Cagenix, BAROnova, SpineForm, Gentis and 11 more.
You May Also Like
SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.
Minimus Spine is developing ozone injection technology specifically for spinal applications. The company has improved upon the existing technology through a system that creates ozone, and measures its concentration, within in a sterile, syringe-cartridge. This has advantages in terms of sterility and dose assurance, as well as material compatibility, which are vital to the advancement of this technique.
Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. The company's KyphX(R) line of products is used in balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. More information about the company can be found at www.kyphon.com.
TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.
Cross Trees Medical offers products for vertebral fracture treatment
Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine, which causes back pain. The company's first patented product, DiscCell, is a breakthrough injectable biomaterial that augments or replaces the diseased nucleus pulposus of the spinal disc.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.